Nanterinone

DB19644ExperimentalSmall molecule

Nanterinone is a small molecule drug. Nanterinone has a monoisotopic molecular weight of 253.12 Da.

Mechanism: Pharmacologically active on Cyclic nucleotide phosphodiesterase and Phosphodiesterase 3
Curator reviewed
Formula / weight: C₁₅H₁₅N₃O · 253.305 g/mol (avg)

Resolves to

Compound

Structure

InChIKeyNMNXBEXPAHSXOK-UHFFFAOYSA-NSMILESCC1=CN(C(C)=N1)C1=CC(C)=C2NC(=O)C=CC2=C1

What you can answer from here — as of September 23, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

2+ReferencesStructured and connected to the statements they support

Which companies are running trials of Nanterinone, in which indications and phases, and which of those programs are still active?

Create a free account or log in to explore the full data card.